Literature DB >> 8109857

An FKBP-rapamycin-sensitive, cyclin-dependent kinase activity that correlates with the FKBP-rapamycin-induced G1 arrest point in MG-63 cells.

M W Albers1, E J Brown, A Tanaka, R T Williams, F L Hall, S L Schreiber.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8109857     DOI: 10.1111/j.1749-6632.1993.tb17142.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein.

Authors:  R T Peterson; B N Desai; J S Hardwick; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  Intramural delivery of Sirolimus prevents vascular remodeling following balloon injury.

Authors:  Michael Buerke; Markus Guckenbiehl; Hansjörg Schwertz; Ute Buerke; Michael Hilker; Herbert Platsch; Joachim Richert; Sabine Bomm; Guy A Zimmerman; Stephan Lindemann; Ursula Mueller-Werdan; Karl Werdan; Harald Darius; Andrew S Weyrich
Journal:  Biochim Biophys Acta       Date:  2006-05-19

3.  Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin.

Authors:  F Nicoletti; C Lapenta; C Lamenta; S Donati; M Spada; A Ranazzi; B Cacopardo; K Mangano; F Belardelli; C Perno; S Aquaro
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

4.  Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.

Authors:  J Chen; X F Zheng; E J Brown; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

5.  Activation of the unfolded protein response in sarcoma cells treated with rapamycin or temsirolimus.

Authors:  Joseph W Briggs; Ling Ren; Kristi R Chakrabarti; Yien Che Tsai; Allan M Weissman; Ryan J Hansen; Daniel L Gustafson; Yousuf A Khan; Jonathan D Dinman; Chand Khanna
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.